VRDN
Viridian Therapeutics, Inc.Healthcare$18.84
◆ Neutral
Mkt Cap: $1.93B|Float: 102.1M|SI: 8.1%|DTC: 6.5
Data as of market close Apr 2, 2026
IV Rank
72
IV Pctl
33%
HV 20d
14482.0%
52W Range
$10-$34
ATR(14)
$1.81
Exp. Move
±13.7%
P/C Ratio
1.83
Earnings
May 6
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
High Put/Call
VRDN Key Options Data
- IV Rank
- 72.1%
- Total GEX
- $-0.00B
- Total DEX
- $0.3M
- Max Pain
- $20.00
- Expected Move
- ±13.7%
- Put/Call OI
- 1.83
- Net Premium
- $0.0M
- Spot Price
- $18.84
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.58 | ±13.7% | $16.27 | $21.42 |
| 2026-05-15 | 43 | ±$4.20 | ±22.3% | $14.64 | $23.04 |
| 2026-07-17 | 106 | ±$2.83 | ±15.0% | $16.02 | $21.67 |
| 2026-10-16 | 197 | ±$4.53 | ±24.0% | $14.32 | $23.37 |
Explore VRDN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.